Potato-Based Milk Enters the Booming Plant-Based Milk Market With a Bang

FN Media Group Presents Microsmallcap.com Market Commentary

 

New York, NY – August 4, 2021 – Plant-based milk has taken the food industry by storm, with products popping up on shelves made from oats, cashews, almonds, coconuts, hazelnuts, walnuts, barley, rice – the list goes on. However, many of these crops, like oats, can be resource-intensive and tricky to harvest, which is why Swedish company Dug is introducing a potato-based milk to the booming plant-based milk market. At the same time, companies within the plant-based food space are continuing to ramp up their plant-based offerings in an effort to gain a larger share of the $7 billion market. Else Nutrition Holdings Inc. (TSXV:BABY) (OTCQX:BABYF) is one of the most innovative companies developing plant-based nutrition for babies and toddlers via its Else Nutrition lines of formula and other products. Companies like KKR & Co. Inc. (NYSE:KKR) and Yum! Brands (NYSE:YUM) collaborated to bring the innovating Violife vegan cheese and Pizza Hut stuffed crust dish to Pizza Hut. Oatly (NASDAQ:OTLY) and Tyson Foods (NYSE:TSN) continue to develop plant-based alternatives that consumers seem to love.

 

Else Nutrition Holdings Inc. (TSXV:BABY) (OTCQX:BABYF) has been on a run, with new products, research and development, and clinical studies coming down the pipeline to advance its position in the plant-based infant nutrition food market. The company announced on July 20 that it had completed a full-scale commercial trial manufacturing run of the ready to drink liquid version of its Plant-Based Complete Nutrition for Toddlers and Kids products after months of R&D trials. This expansion of manufacturing capacity will prepare Else to offer its products in liquid format and enable the brand to penetrate hospitals while opening up an additional 92% of the Kids nutritional drinks market. This $1 billion dollar category in the US brings a vastly larger customer base into the company’s sights.

 

Else also recently announced that it is launching a clinical study to validate the growth benefits of Else’s Plant-Based nutrition. The study will focus on a 4-month period of consumption to see how Else production supports healthy and proper growth in young children vs. cow-milk-based formula.

 

“This is an exciting development for the brand, and we are confident that it will further validate the efficacy of our whole-food-based nutrition products for early childhood,” said Hamutal Yitzhak, CEO, and Co-Founder of Else Nutrition. “Thousands of families across North America have already taken to Else products, and we’ve heard tremendous feedback, including real life-improving cases. This study will only serve as further validation, and can serve us in our Medical Marketing efforts.”

 

Else has also attained FODMAP certification and will be able to use the FODMAP Friendly Certification Trademark on its packaging. The Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) friendly product label ensures that it is safe for those suffering IBS symptoms.

 

To bolster its global medical market, clinical, and regulatory affairs, Else Nutrition announced strategic additions to its team. Two former Abbott Laboratories executives will be added to Else’s executive team – Simeon Saunders will come on board as VP Global Medical Marketing and Scientific Affairs to lead the company’s global medical marketing, clinical and regulatory affairs globally, and Mike Click will join as GM and VP Else North America. After 25 years at Abbott Laboratories, Simeon Saunders will bring experience and skill to the Else team. Mike Glick will lead Else’s US subsidiary expansion and manage operation as the company expands into Canada.

 

An Innovative and Forward-Thinking Industry

 

Global investment company KKR & Co. Inc. (NYSE:KKR) gained its stake in the plant-based food market through the purchase of Violife, an award-winning vegan cheese manufacturer owned by Upfield Group, in 2017. In June, Violife announced a collaboration with legendary hip-hop artist and long-time vegan, RZA to develop the 2021 Plant Grants program, which will focus on helping community-based Black-owned restaurants recover from the impacts of the COVID-19 pandemic through funding to support re-investment in the business and coaching on menu development from two plant-based chef pioneers, Lemel Durrah and Laricia Chandler to inspire the addition of more plant-based dishes to their menus.

 

Yum! Brands (NYSE:YUM) restaurants have also been bolstering their plant-based offerings. Ïzza Hut is collaborating with Violife to launch of Vegan Stuffed Crust with Violife following countless requests for a plant-based alternative to cheese. The new release comes after the successful January launch of its vegan pepperoni pizza, the Pepperphoni, which resulted in almost 40,000 vegan pizzas sales within the month alone.

 

Oatly (NASDAQ:OTLY) expanded its investor base when it went public under the ticker OTLY on the NASDAQ on May 20, 2021. The company is also opening one of the largest plant-based dairy factories in the world in Peterborough, UK. Anticipated to launch in 2023, the factory is expected to create 200 local jobs and will provide Oatly with an end-to-end production solution and facility.

 

Tyson Foods (NYSE:TSN) is proving to be a leader in the industry as it announced on July 22 that it had joined the McDonalds Mutual Commitment to Diversity, Equity, and Inclusion (MCDEI). The plant-based foods industry is a progressive and innovative one, and Tyson Foods is proving it by being an early adopter of this important pledge. Tyson employees speak more than 50 languages across the company and boast a multicultural community of employees.

 

Meanwhile, Else Nutrition Holdings Inc. (TSXV:BABY) (OTCQX:BABYF) is focused on further innovation within the baby, infant and toddler nutrition category with ongoing product launches planned for later this year.

 

To learn more about Else Nutrition Holdings Inc. (TSXV:BABY) (OTCQX:BABYF), click here.

 

Disclaimer:  Microsmallcap.com (MSC) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with MSC or any company mentioned herein. The commentary, views and opinions expressed in this release by MSC are solely those of MSC and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable MSC and FNM for any investment decisions by their readers or subscribers. MSC and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

 

The Article and content related to the profiled company represent the personal and subjective views of the Author (MSC), and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author (MSC) has not independently verified or otherwise investigated all such information. None of the Author, MSC, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment. FNM was not compensated by any public company mentioned herein to disseminate this press release but was compensated twenty five hundred dollars by MSC, a non-affiliated third party to distribute this release on behalf of Else Nutrition

 

FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MSC and FNM undertake no obligation to update such statements.

 

Media Contact:

FN Media Group, LLC

info@financialnewsmedia.com

+1(561)325-8757

 

Source: Microsmallcap.com